• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌肺转移再次切除的结果。

Outcome of surgical resection for recurrent pulmonary metastasis from colorectal carcinoma.

机构信息

Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Higashinari-ku, Japan.

出版信息

Am J Surg. 2011 Oct;202(4):419-26. doi: 10.1016/j.amjsurg.2010.08.016. Epub 2011 Aug 6.

DOI:10.1016/j.amjsurg.2010.08.016
PMID:21824604
Abstract

BACKGROUND

The outcomes after repeat pulmonary resection for colorectal cancer (CRC) and the factors associated with the prognosis of these patients remain uncharacterized.

METHODS

Data on 156 patients who underwent curative resection of pulmonary metastasis from CRC were reviewed. Repeat pulmonary resection was performed in 25 patients; the present study examined the outcomes and factors associated with prognosis after repeat pulmonary resection.

RESULTS

The 5-year survival rate after the first pulmonary resection was 56.2%. A multivariate analysis identified a histological type other than well-differentiated adenocarcinoma, a high prethoracotomy serum carcinoembryonic antigen (CEA) level, and the presence of hilar or mediastinal lymph node metastasis as poor prognostic factors for the first pulmonary resection. The 5-year survival rate after repeat pulmonary resection was 42.1%. Hilar or mediastinal lymph node metastasis at the time of the repeat resection was significantly associated with poor survival.

CONCLUSIONS

Repeat pulmonary resection for metastatic CRC provides satisfactory outcomes. Hilar or mediastinal lymph node involvement is consistently associated with a poor prognosis after the first and repeat pulmonary resections.

摘要

背景

结直肠癌(CRC)患者多次肺切除术后的结果以及与这些患者预后相关的因素尚不清楚。

方法

回顾了 156 例接受结直肠转移灶根治性切除术患者的数据。25 例患者接受了再次肺切除术;本研究探讨了再次肺切除术后的结果和与预后相关的因素。

结果

首次肺切除术后 5 年生存率为 56.2%。多因素分析发现,非高分化腺癌组织学类型、术前血清癌胚抗原(CEA)水平高、存在肺门或纵隔淋巴结转移是首次肺切除术的不良预后因素。再次肺切除术后 5 年生存率为 42.1%。再次切除时存在肺门或纵隔淋巴结转移与生存不良显著相关。

结论

转移性 CRC 的再次肺切除术可获得满意的结果。首次和再次肺切除术后,肺门或纵隔淋巴结受累始终与预后不良相关。

相似文献

1
Outcome of surgical resection for recurrent pulmonary metastasis from colorectal carcinoma.结直肠癌肺转移再次切除的结果。
Am J Surg. 2011 Oct;202(4):419-26. doi: 10.1016/j.amjsurg.2010.08.016. Epub 2011 Aug 6.
2
Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma.手术治疗结直肠癌肺转移患者的益处。
Ann Thorac Surg. 2004 Jul;78(1):238-44. doi: 10.1016/j.athoracsur.2004.02.017.
3
Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.结直肠癌肺转移瘤切除术的预后预测及手术指征
Ann Thorac Surg. 2006 Jul;82(1):254-60. doi: 10.1016/j.athoracsur.2006.02.027.
4
Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.非小细胞肺癌最高纵隔淋巴结转移的预后意义
Ann Thorac Surg. 2006 Jan;81(1):292-7. doi: 10.1016/j.athoracsur.2005.06.077.
5
Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.结直肠癌肺转移切除术后生存的免疫组化预后标志物的鉴定
Thorac Cardiovasc Surg. 2009 Oct;57(7):403-8. doi: 10.1055/s-0029-1185820. Epub 2009 Sep 30.
6
Metastatic tumor doubling time is an independent predictor of intrapulmonary recurrence after pulmonary resection of solitary pulmonary metastasis from colorectal cancer.转移性肿瘤倍增时间是结直肠癌孤立性肺转移灶肺切除术后肺内复发的独立预测因素。
Dig Surg. 2008;25(3):220-5. doi: 10.1159/000140693. Epub 2008 Jun 23.
7
Lung metastases from colorectal cancer: surgical resection and prognostic factors.结直肠癌肺转移:手术切除及预后因素
Eur J Cardiothorac Surg. 2009 Mar;35(3):444-9. doi: 10.1016/j.ejcts.2008.10.047. Epub 2009 Jan 10.
8
Histopathologic prognostic factors in resected colorectal lung metastases.切除的结直肠癌肺转移灶的组织病理学预后因素
Ann Thorac Surg. 2005 Jan;79(1):278-82; discussion 283. doi: 10.1016/j.athoracsur.2004.06.096.
9
More than one pulmonary resections or combined lung-liver resection in 79 patients with metastatic colorectal carcinoma.79 例转移性结直肠癌患者行超过一次的肺切除术或联合肺肝切除术。
J Surg Oncol. 2011 Dec;104(7):781-6. doi: 10.1002/jso.22007. Epub 2011 Jun 28.
10
Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastases.原发结直肠肿瘤切除术后肝和/或肺转移复发行切除术的生存获益的队列研究。
Ann Surg. 2010 May;251(5):902-9. doi: 10.1097/SLA.0b013e3181c9868a.

引用本文的文献

1
The Ugly: Metastatic Colon Cancer-Surgical Options.难点:转移性结肠癌的手术选择
Clin Colon Rectal Surg. 2024 Jun 18;38(3):219-228. doi: 10.1055/s-0044-1787825. eCollection 2025 May.
2
A phase 2 study of adjuvant chemotherapy with 5-fluorouracil/leucovorin and oxaliplatin after lung metastasectomy for colorectal cancer (WJOG5810G).一项关于结直肠癌肺转移瘤切除术后使用5-氟尿嘧啶/亚叶酸钙和奥沙利铂进行辅助化疗的2期研究(WJOG5810G)。
Cancer. 2025 Apr 1;131(7):e35807. doi: 10.1002/cncr.35807.
3
Recurrence-free survival curve for pulmonary metastasectomy in colorectal cancer plateaus at 3 years.
结直肠癌肺转移瘤切除术的无复发生存曲线在3年后趋于平稳。
Updates Surg. 2024 Dec;76(8):2795-2803. doi: 10.1007/s13304-024-01874-8. Epub 2024 May 27.
4
Outcomes and prognostic factors of repeat pulmonary metastasectomy.复发性肺转移瘤切除术的疗效及预后因素
Interdiscip Cardiovasc Thorac Surg. 2024 Mar 5;38(3). doi: 10.1093/icvts/ivae028.
5
Management of single pulmonary metastases from colorectal cancer: State of the art.结直肠癌单发肺转移的管理:最新进展。
World J Gastrointest Oncol. 2022 Apr 15;14(4):820-832. doi: 10.4251/wjgo.v14.i4.820.
6
Thoracoscopic pulmonary metastasectomy in metastatic colorectal cancer: Surgical outcomes and prognostic factors.胸腔镜肺转移切除术治疗结直肠癌肺转移:手术结果和预后因素。
Thorac Cancer. 2021 Oct;12(19):2537-2543. doi: 10.1111/1759-7714.14132. Epub 2021 Aug 29.
7
Prognostic factors in pulmonary metastasectomy and efficacy of repeat pulmonary metastasectomy from colorectal cancer.肺转移瘤切除术的预后因素及结直肠癌肺转移重复切除术的疗效。
World J Surg Oncol. 2020 Nov 30;18(1):314. doi: 10.1186/s12957-020-02076-3.
8
Taiwan Society of Colon and Rectal Surgeons (TSCRS) Consensus for Cytoreduction Selection in Metastatic Colorectal Cancer.台湾结直肠外科医学会转移性结直肠癌减瘤手术选择共识。
Ann Surg Oncol. 2021 Mar;28(3):1762-1776. doi: 10.1245/s10434-020-08914-8. Epub 2020 Sep 1.
9
The short-term outcomes of pulmonary metastasectomy or stereotactic body radiation therapy for pulmonary metastasis from epithelial tumors.上皮性肿瘤肺转移行肺转移瘤切除术或立体定向体部放疗的短期疗效
J Cardiothorac Surg. 2020 Feb 27;15(1):43. doi: 10.1186/s13019-020-1079-4.
10
Proposal of a Useful Surrogate Endpoint of the Overall Survival in Patients Undergoing Pulmonary Metastasectomy: The Time to Local Therapy Failure.提出一个对接受肺转移瘤切除术的患者总生存有意义的替代终点:局部治疗失败时间。
World J Surg. 2019 Oct;43(10):2640-2646. doi: 10.1007/s00268-019-05071-2.